Meso Hour: Tuesday 5 May 2026

Date: Tuesday 5 May Time: 1:00 – 2:00pm Topic: Clinical Trials Speaker: A/Professor Steven Kao, Medical Oncologist Dr Steven Kao is a Medical Oncology Staff Specialist at the Chris O’Brien Lifehouse, Royal Prince Alfred Hospital since 2013, where he has overseen the thoracic oncology clinical service, particularly the programme of malignant mesothelioma. Steven has a wide clinical, translational, and psycho-social research interest in thoracic cancers including malignant mesothelioma and asbestos-related lung cancer. Steven completed his PhD at ADDRI and Sydney University in 2013. His research was focused on predictive and prognostic factors in malignant mesothelioma. With his continuing affiliation at ADDRI, he has continued his translational research in biomarkers and novel therapeutic targets in malignant mesothelioma. He has had several grants as a principal investigator in the field of mesothelioma. He was instrumental in completing the first-in-man phase I trial using a novel delivery system to replace miR15/16 in mesothelioma patients, sponsored by ADDRI. Steven has received many awards in recognition of his research. These include: the Excellence in Translational Cancer Research in the 2014 Premier’s Awards for Outstanding Cancer Research, Cancer Institute NSW; and, the Outstanding Cancer Research Scholar in the 2012 Premier’s Award for Outstanding Cancer Research, Cancer Institute NSW.